Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of individualized treatments remains a challenge. The goal of this study was to determine whether radiomic features extracted from magnetic resonance (MR) images are independently associated with overall survival (OS) in STS. Methods and Materials: This study analyzed 2 independent cohorts of adult patients with stage II-III STS treated at center 1 (N = 165) and center 2 (N = 61). Thirty radiomic features were extracted from pretreatment T1-weighted contrast-enhanced MR images. Prognostic models for OS were derived on the center 1 cohort and validated on the center 2 cohort. Clinical-only (C), radiomics-only (R), and clinical a...
Background: Pediatric soft tissue sarcomas are rare tumors with rhabdomyosarcoma being the most freq...
Current prognostic models for soft tissue sarcoma (STS) patients are solely based on staging informa...
Background: Soft Tissue Malignancies of Musculoskeletal System or sarcomas are a rare and heterogene...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Purpose: In soft tissue sarcoma (STS) patients systemic progression and survival remain comparably l...
Soft Tissue Sarcomas (STS) are among the most dangerous diseases, with a 50% mortality rate...
Background: Treatment decisions for multimodal therapy in soft tissue sarcoma (STS) patients greatly...
Simple SummarySoft-tissue sarcomas constitute a rare cancer type, with approximately 40% of patients...
Objective: To assess the diagnostic performance of morphological MRI features separately and in com...
Purpose: To assess the feasibility of grading soft tissue sarcomas (STSs) using MRI features (radiom...
PURPOSE: In high-grade soft-tissue sarcomas (STS) the standard of care encompasses multimodal therap...
Bone and soft-tissue primary malignant tumors or sarcomas are a large, diverse group of mesenchymal-...
Purpose: In high-grade soft-tissue sarcomas (STS) the standard of care encompasses multimodal therap...
Background: The aim of the study was to evaluate the management, toxicity and treatment responses of...
Background: Pediatric soft tissue sarcomas are rare tumors with rhabdomyosarcoma being the most freq...
Current prognostic models for soft tissue sarcoma (STS) patients are solely based on staging informa...
Background: Soft Tissue Malignancies of Musculoskeletal System or sarcomas are a rare and heterogene...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Purpose: Soft tissue sarcomas (STS) represent a heterogeneous group of diseases, and selection of in...
Purpose: In soft tissue sarcoma (STS) patients systemic progression and survival remain comparably l...
Soft Tissue Sarcomas (STS) are among the most dangerous diseases, with a 50% mortality rate...
Background: Treatment decisions for multimodal therapy in soft tissue sarcoma (STS) patients greatly...
Simple SummarySoft-tissue sarcomas constitute a rare cancer type, with approximately 40% of patients...
Objective: To assess the diagnostic performance of morphological MRI features separately and in com...
Purpose: To assess the feasibility of grading soft tissue sarcomas (STSs) using MRI features (radiom...
PURPOSE: In high-grade soft-tissue sarcomas (STS) the standard of care encompasses multimodal therap...
Bone and soft-tissue primary malignant tumors or sarcomas are a large, diverse group of mesenchymal-...
Purpose: In high-grade soft-tissue sarcomas (STS) the standard of care encompasses multimodal therap...
Background: The aim of the study was to evaluate the management, toxicity and treatment responses of...
Background: Pediatric soft tissue sarcomas are rare tumors with rhabdomyosarcoma being the most freq...
Current prognostic models for soft tissue sarcoma (STS) patients are solely based on staging informa...
Background: Soft Tissue Malignancies of Musculoskeletal System or sarcomas are a rare and heterogene...